|
Author year, country | Age/sex | Past history/predisposing conditions/cancer/HCST | Immune suppression | Likely risk factor/inciting event | Reason for admission/Clinical presentation | Initial antibiotics | Response to initial antibiotics/subsequent antibiotics | Specimen source positive for Herbaspirillum |
|
Liu 2019, Korea | 93/F | Hypertension Advanced age | N/A | — | (i) Fever, seizure (ii) After a few days, hypoxia and chest X-ray with pneumonia | Empiric vancomycin + ceftriaxone for encephalitis | Changed to meropenem and colistin at 10 days and changed to ceftazidime, minocycline, and trimethoprim/sulfamethoxazole thereafter | Blood: Herbaspirillum huttiense 2 months later, sputum: Herbaspirillum huttiense |
Abreu-di berardino 2019, Spain | 59/F | Aortic wall thrombosis, visceral and cerebral ischemic lesions, JAK2 + essential thrombocytopenia, new DM | N/A | — | (i) Generalized deconditioning (ii) Dyspnea 10 days after admission, nosocomial pneumonia | Piperacillin-tazobactam | Recovered completely after antibiotics | Sputum: Herbaspirillum huttiense |
Chen 2010, China | 48/F | Acute lymphoblastic leukemia | On chemotherapy and G-CSF | Drank sugarcane juice before fever started | Fever, chills | Cefmetazole and gatifloxacin | Improved | Blood: Herbaspirillum huttiense |
Spilker 2008, USA | 26/m | Moderate to severe lung disease, pancreatic insufficiency, diabetes, and liver disease | Recent multiple admissions for exacerbation of respiratory symptoms | — | Fevers and rigors, MRSA, and Pseudomonas aeruginosa bacteremia | Vancomycin, piperacillin-tazobactam, and tobramyicn x 20 days Antibiotic discontinued at 20 days, after FEV1 started to improve | On the hospital day 23: fever and rigors Changed to intravenous ceftazidime and tobramycin and oral trimethoprim-sulfamethoxazole (TMP-SMX), levofloxacin, and minocycline | Blood: (GNR, initially identified as burkholderia cepacia complex) Later, identified as Herbaspirillum species |
Tan 2005, USA | 49/m | Probable hepatic cirrhosis | — | Homeless Jumped from a bridge into a freshwater canal in central Florida | Increasing erythema and warmth to the left leg (cellulitis) | Ampicillin/sulbactam | Antibiotics switched to cefepime and levofloxacin after initial blood culture results | Blood: (oxidase-positive nonlactose-fermenting GNR,submitted to an outside reference laboratory) positive for Herbaspirillum seropedicae |
Regunath 2014, USA | 46/M | Childhood asthma, atypical pneumonia as a teenager, tonsillectomy | N/A | Farming in rural Missouri, close contact with cattle and turkeys, mold and possible rat excreta Drenched in rain during a fishing trip | Fever, fatigue, SOB, night sweats, anorexia, myalgia, and headache Dry cough, right-sided pleuritic chest pain, and worsening dyspnea Hypoxia (multilobar pneumonia) | Vancomycin, ceftriaxone, and azithromycin | Ceftriaxone switched to piperacillin-tazobactam Azithromycin switched to Doxycycline After 12 days of treatment, the patient improved and was extubated | Blood (Day 1) (from referring facility) identified as Burkholderia cepacia complex (BCC),later as Herbaspirillum aquaticum or Herbaspirillum huttiense BAL (Day 3): GNR as Herbaspirillum aquaticum or Herbaspirillum huttiense |
Chemaly 2015, USA | | | | | | | | |
Hospital-based cluster of Herbaspirillium sp infections initially misidentified as B. cepacia | 48/F | Ovarian adenocarcinoma | Chemotherapy | Source and mechanism of the cluster unknown | Pseudomonas BSI, sepsis-CRBSI | Cefepime (5 patients), ceftazidime (1 patient), moxifloxacin (1 patient), meropenem (1 patient) initially Followed by ceftriaxone or fluoroquinolone | All patients improved with antibiotic and had negative repeat blood cultures 1 patient had recurrence, which resolved once the port was removed | Blood, Infusaport tip |
67/F | Leukemia | Chemotherapy | | MRSA pneumonia, sepsis-BSI | | | Blood |
58/M | Leukemia/HSCT | High-dose steroid | | GI bleed GVHD, BSI | | | Blood |
55/F | Leukemia/HSCT | High-dose steroid | | GI GVHD, BSI | | | Blood |
2/M | Ependymoma | High-dose steroid | | Herbaspirillium Sepsis-BSI | | | Blood |
3 additional Herbaspirillium sp after continued surveillance (sporadic) | 66/F | History of recurrent pneumonia, lung cancer | Radiation therapy | | Herbaspirillium Sepsis-pneumonia | | | Sputum |
18/M | Lymphoma | Chemotherapy | | Chemotherapy Sepsis-BSI | | | Blood |
51/F | Aplastic anemia/HSCT | Tacrolimus | | Herbaspirillium Sepsis- CRBSI | | | Blood, PICC line tip |
Suwantarat 2015, USA | 65/M | Multiple myeloma ESRD on hemodialysis | Steroids and lenalidomide | | Acute respiratory failure and septic shock Right lower lobe pneumonia | Vancomycin, cefepime, ciprofloxacin, and micafungin | Changed to vancomycin, meropenem, and gentamicin within 12 hours However, the patient remained clinically unstable and died after 4 days | BAL (oxidase-positive, nonlactose-fermenting GNR), initially identified as Cupriavidus, later as Herbaspirillum Blood: Herbaspirillum seropedicae |
Ziga 2010, USA | 2/F | Acute lymphoblastic leukemia | Chemotherapy, HSCT | Uncertain Lives with her parents and grandparents on a large farm | Fever and diarrhea | Cefepime | Gentamicin added after oxidase-positive, weakly catalase-positive, Gram-negative bacillus Later, switched to meropenem | Blood Burkholderia cepacia complex As susceptibility pattern was not consistent, further identification was pursued: Herbaspirillum sp |
|